Vol. 2 No. 5 (2006) | Hematology Meeting Reports

Current Issue

Vol. 2 No. 5 (2006)

8 June 2009

View this Issue

Vol. 2 No. 5 (2006)

Published: 8 June 2009

Bortezomib (Velcade®) in multiple myeloma: an update

Abstracts

Bortezomib: introduction

Alessandro Corso

https://doi.org/10.4081/hmr.v2i5.379

360

PDF: 313
- PDF
An update of the apex study

Alessandro Corso

https://doi.org/10.4081/hmr.v2i5.380

396

PDF: 1445
- PDF
Bortezomib-combination based therapy in relapsed-refractory myeloma patients

Patrizia Zappasodi

https://doi.org/10.4081/hmr.v2i5.381

322

PDF: 1440
- PDF
Bortezomib in newly diagnosed multiple myeloma patients

Silvia Mangiacavalli

https://doi.org/10.4081/hmr.v2i5.382

252

PDF: 372
- PDF
Frequency and characteristics of hematologic and non-hematologic Bortezomib-related toxicity

Marzia Varettoni

https://doi.org/10.4081/hmr.v2i5.383

267

PDF: 1868
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.